Skip to content

ELV

Elevance Health, Inc.

EBITDA, 2025
$8.7B
YoY, 2025
−5.5%
5-year CAGR
+3.1%
10-year CAGR
+4.4%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$8.7B−5.5%
2024$9.3B−9.7%
2023$10.2B+2.9%
2022$10.0B+12.4%
2021$8.9B+17.9%
2020$7.5B+5.4%
2019$7.1B+8.8%
2018$6.6B+29.5%
2017$5.1B−11.3%
2016$5.7B+0.9%
2015$5.7B+7.4%
2014$5.3B+7.3%
2013$4.9B+12.6%
2012$4.4B−1.3%
2011$4.4B−5.5%
2010$4.7B−1.2%
2009$4.7B−3.8%
2008$4.9B—